Healthcare

United States Antibody Drug Conjugate Market Report 2017

  • QYR1554732
  • 113 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Antibody Drug Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast).

United States Antibody Drug Conjugate market competition by top manufacturers/players, with Antibody Drug Conjugate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Seattle Genetics/Takeda

Roche

ImmunoGen

Immunomedics

Pfizer

Celldex Therapeutics

Millennium Pharmaceuticals

Bayer HealthCare

Mersana Therapeutics

Heidelberg Pharma

Oxford BioTherapeutics

Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Adcetris

Kadcyl

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drug Conjugate for each application, including

Hospital

Pharmaceutical Company

Research Institutions

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Antibody Drug Conjugate Market Report 2017

1 Antibody Drug Conjugate Overview

1.1 Product Overview and Scope of Antibody Drug Conjugate

1.2 Classification of Antibody Drug Conjugate by Product Category

1.2.1 United States Antibody Drug Conjugate Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Antibody Drug Conjugate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Adcetris

1.2.4 Kadcyl

1.2.5 Other

1.3 United States Antibody Drug Conjugate Market by Application/End Users

1.3.1 United States Antibody Drug Conjugate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Pharmaceutical Company

1.3.4 Research Institutions

1.4 United States Antibody Drug Conjugate Market by Region

1.4.1 United States Antibody Drug Conjugate Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Antibody Drug Conjugate Status and Prospect (2012-2022)

1.4.3 Southwest Antibody Drug Conjugate Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Antibody Drug Conjugate Status and Prospect (2012-2022)

1.4.5 New England Antibody Drug Conjugate Status and Prospect (2012-2022)

1.4.6 The South Antibody Drug Conjugate Status and Prospect (2012-2022)

1.4.7 The Midwest Antibody Drug Conjugate Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Antibody Drug Conjugate (2012-2022)

1.5.1 United States Antibody Drug Conjugate Sales and Growth Rate (2012-2022)

1.5.2 United States Antibody Drug Conjugate Revenue and Growth Rate (2012-2022)

2 United States Antibody Drug Conjugate Market Competition by Players/Suppliers

2.1 United States Antibody Drug Conjugate Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Antibody Drug Conjugate Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Antibody Drug Conjugate Average Price by Players/Suppliers (2012-2017)

2.4 United States Antibody Drug Conjugate Market Competitive Situation and Trends

2.4.1 United States Antibody Drug Conjugate Market Concentration Rate

2.4.2 United States Antibody Drug Conjugate Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antibody Drug Conjugate Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Antibody Drug Conjugate Sales and Market Share by Region (2012-2017)

3.2 United States Antibody Drug Conjugate Revenue and Market Share by Region (2012-2017)

3.3 United States Antibody Drug Conjugate Price by Region (2012-2017)

4 United States Antibody Drug Conjugate Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Antibody Drug Conjugate Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017)

4.3 United States Antibody Drug Conjugate Price by Type (2012-2017)

4.4 United States Antibody Drug Conjugate Sales Growth Rate by Type (2012-2017)

5 United States Antibody Drug Conjugate Sales (Volume) by Application (2012-2017)

5.1 United States Antibody Drug Conjugate Sales and Market Share by Application (2012-2017)

5.2 United States Antibody Drug Conjugate Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Antibody Drug Conjugate Players/Suppliers Profiles and Sales Data

6.1 Seattle Genetics/Takeda

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Antibody Drug Conjugate Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Roche

6.2.2 Antibody Drug Conjugate Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 ImmunoGen

6.3.2 Antibody Drug Conjugate Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Immunomedics

6.4.2 Antibody Drug Conjugate Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Pfizer

6.5.2 Antibody Drug Conjugate Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Celldex Therapeutics

6.6.2 Antibody Drug Conjugate Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Millennium Pharmaceuticals

6.7.2 Antibody Drug Conjugate Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Bayer HealthCare

6.8.2 Antibody Drug Conjugate Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Mersana Therapeutics

6.9.2 Antibody Drug Conjugate Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Heidelberg Pharma

6.10.2 Antibody Drug Conjugate Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Oxford BioTherapeutics

6.12 Takeda Pharmaceutical Company Limited

7 Antibody Drug Conjugate Manufacturing Cost Analysis

7.1 Antibody Drug Conjugate Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Antibody Drug Conjugate

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Antibody Drug Conjugate Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Antibody Drug Conjugate Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Antibody Drug Conjugate Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Antibody Drug Conjugate Sales Volume Forecast by Type (2017-2022)

11.3 United States Antibody Drug Conjugate Sales Volume Forecast by Application (2017-2022)

11.4 United States Antibody Drug Conjugate Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Antibody Drug Conjugate

Figure United States Antibody Drug Conjugate Market Size (K Units) by Type (2012-2022)

Figure United States Antibody Drug Conjugate Sales Volume Market Share by Type (Product Category) in 2016

Figure Adcetris Product Picture

Figure Kadcyl Product Picture

Figure Other Product Picture

Figure United States Antibody Drug Conjugate Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Antibody Drug Conjugate by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Pharmaceutical Company Examples

Table Key Downstream Customer in Pharmaceutical Company

Figure Research Institutions Examples

Table Key Downstream Customer in Research Institutions

Figure United States Antibody Drug Conjugate Market Size (Million USD) by Region (2012-2022)

Figure The West Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antibody Drug Conjugate Sales (K Units) and Growth Rate (2012-2022)

Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antibody Drug Conjugate Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Antibody Drug Conjugate Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Antibody Drug Conjugate Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antibody Drug Conjugate Sales Share by Players/Suppliers

Figure 2017 United States Antibody Drug Conjugate Sales Share by Players/Suppliers

Figure United States Antibody Drug Conjugate Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Antibody Drug Conjugate Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Antibody Drug Conjugate Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antibody Drug Conjugate Revenue Share by Players/Suppliers

Figure 2017 United States Antibody Drug Conjugate Revenue Share by Players/Suppliers

Table United States Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Antibody Drug Conjugate Market Share of Top 3 Players/Suppliers

Figure United States Antibody Drug Conjugate Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Antibody Drug Conjugate Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Antibody Drug Conjugate Product Category

Table United States Antibody Drug Conjugate Sales (K Units) by Region (2012-2017)

Table United States Antibody Drug Conjugate Sales Share by Region (2012-2017)

Figure United States Antibody Drug Conjugate Sales Share by Region (2012-2017)

Figure United States Antibody Drug Conjugate Sales Market Share by Region in 2016

Table United States Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Antibody Drug Conjugate Revenue Share by Region (2012-2017)

Figure United States Antibody Drug Conjugate Revenue Market Share by Region (2012-2017)

Figure United States Antibody Drug Conjugate Revenue Market Share by Region in 2016

Table United States Antibody Drug Conjugate Price (USD/Unit) by Region (2012-2017)

Table United States Antibody Drug Conjugate Sales (K Units) by Type (2012-2017)

Table United States Antibody Drug Conjugate Sales Share by Type (2012-2017)

Figure United States Antibody Drug Conjugate Sales Share by Type (2012-2017)

Figure United States Antibody Drug Conjugate Sales Market Share by Type in 2016

Table United States Antibody Drug Conjugate Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Antibody Drug Conjugate Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Antibody Drug Conjugate by Type (2012-2017)

Figure Revenue Market Share of Antibody Drug Conjugate by Type in 2016

Table United States Antibody Drug Conjugate Price (USD/Unit) by Types (2012-2017)

Figure United States Antibody Drug Conjugate Sales Growth Rate by Type (2012-2017)

Table United States Antibody Drug Conjugate Sales (K Units) by Application (2012-2017)

Table United States Antibody Drug Conjugate Sales Market Share by Application (2012-2017)

Figure United States Antibody Drug Conjugate Sales Market Share by Application (2012-2017)

Figure United States Antibody Drug Conjugate Sales Market Share by Application in 2016

Table United States Antibody Drug Conjugate Sales Growth Rate by Application (2012-2017)

Figure United States Antibody Drug Conjugate Sales Growth Rate by Application (2012-2017)

Table Seattle Genetics/Takeda Basic Information List

Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Roche Basic Information List

Table Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Roche Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Roche Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table ImmunoGen Basic Information List

Table ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure ImmunoGen Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure ImmunoGen Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Immunomedics Basic Information List

Table Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Immunomedics Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Immunomedics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Immunomedics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Pfizer Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Pfizer Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Celldex Therapeutics Basic Information List

Table Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Celldex Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Celldex Therapeutics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Millennium Pharmaceuticals Basic Information List

Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bayer HealthCare Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Bayer HealthCare Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Mersana Therapeutics Basic Information List

Table Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Mersana Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Mersana Therapeutics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Heidelberg Pharma Basic Information List

Table Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Heidelberg Pharma Antibody Drug Conjugate Sales Growth Rate (2012-2017)

Figure Heidelberg Pharma Antibody Drug Conjugate Sales Market Share in United States (2012-2017)

Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)

Table Oxford BioTherapeutics Basic Information List

Table Takeda Pharmaceutical Company Limited Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antibody Drug Conjugate

Figure Manufacturing Process Analysis of Antibody Drug Conjugate

Figure Antibody Drug Conjugate Industrial Chain Analysis

Table Raw Materials Sources of Antibody Drug Conjugate Major Players/Suppliers in 2016

Table Major Buyers of Antibody Drug Conjugate

Table Distributors/Traders List

Figure United States Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Antibody Drug Conjugate Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Type in 2022

Table United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Application in 2022

Table United States Antibody Drug Conjugate Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Antibody Drug Conjugate Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antibody Drug Conjugate Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370